Your browser doesn't support javascript.
loading
Protocol for the development of a Core Outcome Set (COS) for Adolescents and Young Adults (AYAs) with cancer.
Husson, Olga; Janssen, Silvie H M; Reeve, Bryce B; Sodergren, Samantha C; Cheung, Christabel K; McCabe, Martin G; Salsman, John M; van der Graaf, Winette T A; Darlington, Anne-Sophie.
Afiliación
  • Husson O; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Janssen SHM; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Reeve BB; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Sodergren SC; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Cheung CK; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • McCabe MG; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
  • Salsman JM; Duke Cancer Institute, Durham, NC, USA.
  • van der Graaf WTA; School of Health Sciences, University of Southampton, Southampton, UK.
  • Darlington AS; School of Social Work, University of Maryland, Baltimore, MD, USA.
BMC Cancer ; 24(1): 126, 2024 Jan 24.
Article en En | MEDLINE | ID: mdl-38267900
ABSTRACT

BACKGROUND:

Adolescents and young adults (AYAs) with cancer, defined as individuals aged 15-39 years at initial cancer diagnosis, form a unique population; they face age-specific issues as they transition to adulthood. This paper presents the protocol for the development of a core outcome set (COS) for AYAs with cancer.

METHODS:

The methodological standards from the Core Outcome Measures in Effectiveness Trials (COMET) and the International Consortium for Health Outcomes Measurement (ICHOM) for COS development will guide the development of the COS for AYAs with cancer. The project will consist of the following phases (1) define the scope of the COS; (2) establish the need for a COS in this field (3) assemble an international, multi-stakeholder working group; (4) develop a detailed protocol; (5) determine "what to measure" (i.e., outcomes); (6) determine "how to measure" (i.e., measures); and (7) determine "case-mix" variables.

CONCLUSIONS:

The development of a COS for AYAs with cancer will facilitate the implementation of efficient and relevant standards for data collection, both for clinical trials and in routine healthcare, thereby increasing the usefulness of these data to improve the value of the care given to these underserved young cancer patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Instituciones de Salud / Neoplasias Tipo de estudio: Diagnostic_studies / Guideline Límite: Adolescent / Adult / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Instituciones de Salud / Neoplasias Tipo de estudio: Diagnostic_studies / Guideline Límite: Adolescent / Adult / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos